The eu market for phase ii ib & iv studies
Pharmacovigilance Guideline
pharmacovigilance in india-by dr.nagaraja prasad.s
PSURs-Volume9b
European Medicines Agency: Good Practice Guide
POSTMARKETING ADVERSE DRUG EXPERIENCE INSPECTIONAL PROGRAM CDR Thomas R. Berry, RPh FDA, Investigator RAL-RP / ATL-DO.
